NCT07180147 · ACTIVE NOT RECRUITING
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
ALOHA is an observational study tracking brain and body health in adults 50 and older in the Washington D.C. area over five years. Participants get a full health assessment each year — physical, cognitive, and lifestyle — and receive a personalized Health Passport with tailored wellness recommendations. There is no drug or experimental treatment involved. The study watches how health changes over time and whether those recommendations influence behavior and independence. Phase is unspecified, meaning it is not a traditional clinical drug trial.
You may qualify if
- Age 50 years or older at time of enrollment
- Residing in the Washington, District of Columbia (DC)., Maryland, or Virginia metropolitan areas
- Community-dwelling (living independently or with minimal assistance)
- Able to participate in physical and cognitive assessments
- Able to provide informed consent
- Willing to return for annual follow-up assessments for up to 5 years
You're excluded if
- Diagnosis of dementia or significant cognitive impairment that prevents informed consent or participation in assessments
- Severe physical disability or medical condition that precludes participation in study assessments (e.g., unstable cardiac condition, severe mobility limitation)
- Current diagnosis of a terminal illness with life expectancy less than 12 months
- Residing in a long-term care facility or nursing home at time of enrollment
- Inability to communicate in English or Spanish (study materials available in these languages only)
- Participation in another interventional trial that could confound study results
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-03-09